DSIP success rate: what the actual research shows

Last updated 2026-07-30

what is the actual success rate of dsip for sleep

There isn't one. No regulatory body, meta-analysis, or systematic review has published a success rate, response rate, or percentage figure for DSIP improving human sleep. If you see a number like "73% of users report better sleep" on a supplement site, ask for the citation. It won't lead anywhere real. What exists instead is a small cluster of human trials from the 1970s through the 1990s, most with fewer than 20 participants, looking at EEG sleep architecture rather than subjective sleep quality or insomnia diagnoses. Some found statistically significant shifts in specific sleep stages. Others found nothing distinguishable from placebo. None of them used the outcome measures a modern sleep researcher would need to call something a "success", like validated insomnia severity scales, polysomnography across multiple nights, or replication in an independent lab. The honest answer is: DSIP has a thin, old, mixed human evidence base, and it has never cleared the bar of a phase 2 or phase 3 trial for insomnia or any FDA-recognized sleep indication ^[1]. Anyone citing a precise success percentage is making it up or extrapolating far past what the data supports.

what did the original human dsip sleep studies actually find

DSIP (delta sleep-inducing peptide) was first isolated from the blood of rabbits in a cross-perfusion sleep experiment published by Monnier and colleagues in 1977, which is where the name and the sleep association both originate ^[2]. The idea was that a substance in the blood of a sleeping rabbit induced delta-wave (slow-wave) activity when transferred to another animal. That is an animal, cross-circulation finding, not a human sleep result, and it's worth being precise about that distinction because a lot of marketing copy blurs it. Human work followed in small pilot studies. A frequently cited one is Schneider-Helmert's work in the early 1980s giving DSIP to patients with chronic insomnia; some reports describe modest improvements in sleep continuity and reduced nighttime awakenings in a subset of subjects ^[3]. But sample sizes were small, dosing was inconsistent across studies (some intravenous, some intramuscular), and follow-up periods were short. Other trials from the same era, testing DSIP for conditions like alcohol withdrawal or stress-related sleep disruption, produced inconsistent or null results on primary sleep measures. No large-scale, placebo-controlled, pre-registered human trial for DSIP and sleep exists in the modern sense. Nothing has been repeated with contemporary methodology (actigraphy, standardized insomnia diagnostic criteria, multi-night polysomnography) since the original wave of research wound down decades ago.

is there any recent human research on dsip

Essentially no new human clinical trials on DSIP for sleep have been published in the last two decades. A search of ClinicalTrials.gov and PubMed turns up the same handful of legacy studies from the 1970s-1990s cited repeatedly, with no modern registered trials testing DSIP against placebo for insomnia or sleep quality in humans. This matters because sleep research methodology changed a lot since then. Modern trials use validated tools like the Pittsburgh Sleep Quality Index or the Insomnia Severity Index, multi-night at-home polysomnography, and pre-registered statistical plans. None of the original DSIP studies used this toolkit, because it largely didn't exist yet or wasn't standardized. So when someone asks whether DSIP "works", the accurate response is that we're relying on evidence collected before the field had the tools to answer that question rigorously. That's not a knock on the original researchers, it's just a fact about when the work was done. If you want the fuller picture of what these old studies do and don't show, the dsip reviews page walks through the individual papers in more depth.

what does dsip do in the body according to the research

DSIP is a nonapeptide, a chain of nine amino acids, first described as a factor that appeared in rabbit cerebrospinal fluid and blood during slow-wave sleep states ^[2]. Beyond the sleep angle, researchers have looked at DSIP's relationship to the hypothalamic-pituitary-adrenal (HPA) axis, the system that governs cortisol release under stress. Some animal studies suggest DSIP may blunt stress-induced ACTH and corticosterone spikes ^[4]. That stress-axis angle is part of why DSIP gets discussed alongside sleep, since chronic stress and elevated cortisol are known disruptors of sleep architecture in humans, documented extensively in endocrinology literature independent of DSIP itself ^[5]. But connecting "DSIP blunts stress hormones in rats" to "DSIP will improve your sleep tonight" requires several unproven leaps. Nobody has demonstrated that mechanism translating into a measurable, repeatable human sleep benefit in controlled conditions. It's also worth noting DSIP is not currently approved by the FDA for any human indication. It isn't a recognized drug, and it isn't a dietary supplement with an established safety monograph either. It sits in a research-chemical category, which shapes how it's sold and who sells it responsibly.

how many people were in the dsip clinical trials

Small. This is one of the most underappreciated facts about DSIP research. The original human sleep studies typically enrolled somewhere between 8 and 20 subjects, and some case-series work involved single-digit patient counts ^[3]. That's a pilot-study scale, useful for hypothesis generation, not for establishing an efficacy rate you'd feel confident acting on. For comparison, a modern FDA-reviewed insomnia drug trial for something like suvorexant enrolled thousands of subjects across multi-site, multi-month, placebo-controlled protocols before approval ^[6]. That gap in scale, dozens of subjects decades ago versus thousands of subjects in a modern registration trial, is the single biggest reason nobody can honestly state a DSIP success rate. The statistical power to detect a real effect, and rule out a false one, just isn't there in the DSIP literature.

why do people online claim high dsip success rates anyway

Because anecdote spreads faster than nuance, and because "nine amino acids linked to sleep" is a compelling story even without a real percentage attached to it. Forum posts, Reddit threads, and supplement retailer copy often cite user-reported improvement without any control group, blinding, or standardized measurement. That's not fraud necessarily, it's just how self-reported anecdotal data behaves: people who feel better after trying something are more likely to post about it than people who felt nothing. Some retailers also conflate the original animal cross-perfusion finding from Monnier's rabbit experiments with a human efficacy claim, which is a real category error worth flagging every time you see it ^[2]. A rabbit's brain wave pattern changing after a blood transfusion from another sleeping rabbit is not the same claim as "humans who take DSIP sleep better", even though both get cited under the same umbrella term. If you're trying to figure out realistic expectations before trying anything, the dsip before and after page and the dsip results timeline page both cover what people typically report anecdotally, clearly labeled as self-reported and not clinical outcome data.

does dsip help with stress or just sleep

The stress angle has slightly more mechanistic animal support than the sleep angle does, but it's still animal-level evidence, not confirmed in controlled human trials. Several rodent studies from the 1980s and 1990s examined DSIP's effect on the HPA axis and found it appeared to reduce ACTH and corticosterone responses to acute stressors in some experimental conditions ^[4]. That's interesting pharmacology. It is not the same as demonstrating that DSIP reduces perceived stress, cortisol, or anxiety symptoms in humans under controlled, blinded conditions. No human trial has replicated a stress-hormone-blunting effect with the rigor you'd want before making a health claim. So if someone asks "does DSIP help with stress", the honest answer splits in two: animal data suggests a plausible mechanism worth studying further, and human confirmation of that mechanism, at meaningful effect sizes, doesn't currently exist in the published record.

how does dsip compare to melatonin or other sleep compounds

Melatonin has an enormous, messy, but real human evidence base: dozens of randomized controlled trials, meta-analyses, and an NIH-recognized mechanism as a circadian signal hormone, with the National Center for Complementary and Integrative Health summarizing evidence that it can modestly reduce the time it takes to fall asleep in some populations ^[7]. DSIP has nothing comparable in scale or recency. That doesn't automatically make DSIP worse as a compound, mechanistically these substances work through completely different pathways, melatonin via circadian receptors, DSIP allegedly via some undetermined interaction with sleep architecture and the HPA axis. But in terms of evidence volume and quality, they are not in the same category. Melatonin has been studied in trials with hundreds to thousands of participants repeated across multiple decades. DSIP has a handful of small studies that mostly stopped being replicated after the 1990s. If you're weighing whether DSIP is worth trying at all given this gap, the is dsip worth it page addresses that decision directly, and the dsip pros and cons page lays out the tradeoffs without the marketing gloss.

what would it take to actually establish a dsip success rate

A modern trial, run to current standards, with a real sample size. Specifically: a randomized, double-blind, placebo-controlled design; at least 100-200 participants to have reasonable statistical power; validated outcome measures like the Insomnia Severity Index or actigraphy-confirmed sleep efficiency; and pre-registration on a platform like ClinicalTrials.gov so outcomes can't be selectively reported after the fact. None of that currently exists for DSIP. Until it does, any specific number, 60%, 70%, 80% "success", reported for DSIP and sleep is not traceable to a real study and shouldn't be treated as more than a marketing estimate. This is also why regulatory status matters here. Compounds without FDA-approved human indications don't go through the same scrutiny, dosing standardization, or adverse event reporting infrastructure that approved sleep medications do. That's a structural reason to be more, not less, careful with claims made about them.

what should someone realistically expect if they try dsip

Honestly: uncertainty. The published human data is old, small, and mixed, some studies show modest EEG-level changes in slow-wave sleep, others show nothing distinguishable from placebo, and none give you a percentage chance of a specific outcome. Anyone telling you DSIP works for a specific share of users is going beyond what the record supports. If you're going to look into it further, do it with that framing intact rather than expecting sleep-medication-level certainty. Read the actual studies (or summaries of them) rather than relying on retailer testimonials, check whether a source is describing animal or human data, and treat any specific percentage claim as a red flag rather than a selling point. For sourcing decisions specifically, work only through a provider-reviewed pathway rather than unverified retail listings, since DSIP is not FDA-approved for any indication and quality control varies widely across sellers. DSIP Peptide reviews providers and points readers toward routes fulfilled through vetted pharmacy partners rather than selling or compounding anything itself. If you're at the point of deciding whether it's even worth pursuing given the state of the evidence, that's exactly what the is dsip worth it and dsip first month what to expect pages are built to help with.

Frequently asked questions

Is there a published DSIP success rate for sleep?

No. No peer-reviewed source publishes a success rate, response rate, or percentage for DSIP improving human sleep. The existing studies are small, from the 1970s-1990s, and report mixed EEG findings rather than a summary efficacy percentage. Any specific number quoted online isn't backed by a traceable citation.

How many people were studied in the original DSIP sleep trials?

Most original human DSIP sleep studies enrolled somewhere between 8 and 20 subjects, a pilot-study scale. That's far below the hundreds to thousands of participants typically enrolled in modern FDA-reviewed insomnia drug trials, which is a major reason no reliable efficacy rate exists for DSIP.

Was DSIP tested in humans or just animals?

Both, but the split matters. DSIP was first identified through rabbit cross-perfusion experiments in 1977. Some small human trials followed in the 1980s-90s looking at EEG changes in insomnia patients, but sample sizes were tiny and results were mixed, not the large human efficacy trials the name implies.

Does DSIP have FDA approval for sleep or any condition?

No. DSIP is not FDA-approved for insomnia, stress, or any other human indication. It's studied as a research compound, not sold as an approved drug or a regulated dietary supplement with an established safety monograph.

Why do some people report DSIP helped their sleep?

Self-reported anecdotes aren't controlled data. People who feel improvement are more likely to post about it, creating a skewed picture online. Without blinding or a placebo group, it's impossible to separate a real effect from expectation, natural sleep variability, or unrelated lifestyle changes happening at the same time.

How does DSIP's evidence compare to melatonin's?

Melatonin has dozens of randomized controlled trials and meta-analyses across decades, summarized by NIH's NCCIH as modestly reducing time to fall asleep in some studies. DSIP has a handful of small, decades-old studies with no recent replication, making the evidence bases very different in size and recency.

Can DSIP help with stress, more than sleep?

Animal studies suggest DSIP may blunt stress-hormone (ACTH, corticosterone) responses in rodents, but this hasn't been confirmed in controlled human trials. The mechanism is plausible and worth studying further, but no rigorous human data currently backs a stress-reduction claim.

Are there any recent clinical trials on DSIP?

No substantial new human clinical trials on DSIP and sleep have been published in roughly the last two decades. Searches of ClinicalTrials.gov and PubMed return the same original studies from the 1970s-1990s, with no modern registered trials testing DSIP against placebo.

What sample size would a real DSIP efficacy study need?

Sleep researchers generally consider 100-200 participants a reasonable minimum for adequate statistical power in a placebo-controlled insomnia trial, alongside validated tools like the Insomnia Severity Index and actigraphy. No published DSIP study has approached that scale.

Is DSIP the same thing as a sleeping pill?

No. DSIP is a nine-amino-acid peptide studied experimentally, not an approved pharmaceutical sleep aid. Unlike FDA-approved hypnotics such as suvorexant, which went through large multi-site trials before approval, DSIP has never completed that regulatory pathway for any indication.

Where can I read the actual DSIP studies instead of marketing claims?

Start with the original 1977 Monnier paper describing DSIP's isolation and the small human trials from Schneider-Helmert's group in the early 1980s, both indexed on PubMed. Reading the primary sources directly, rather than retailer summaries, is the only way to see what was actually measured and found.

Should sample size and study age change how I interpret DSIP claims?

Yes. Small samples (often under 20 people) and study designs from the 1970s-90s mean results can't reliably predict what would happen in a modern, larger, better-controlled trial. Treat any confident efficacy claim built on this evidence base with real skepticism.

Sources

1. U.S. Food and Drug Administration, Drug Approvals and Databases: DSIP has no FDA-approved indication for insomnia or any sleep disorder
2. Monnier M, et al., 1977 (PubMed): DSIP was first isolated and described via rabbit cross-perfusion sleep experiments in 1977
3. Schneider-Helmert D, 1985 (PubMed): Small human DSIP trials in chronic insomnia patients reported mixed effects on sleep continuity
4. Graf M, Kastin AJ, 1986 (PubMed), review of DSIP research: Animal studies suggest DSIP may reduce ACTH and corticosterone stress responses
5. National Institute of Neurological Disorders and Stroke, Brain Basics: Understanding Sleep: Chronic stress and cortisol dysregulation are established disruptors of human sleep architecture
6. U.S. Food and Drug Administration, Belsomra (suvorexant) Approval: FDA-approved insomnia drug trials such as suvorexant's enrolled thousands of participants across multi-site studies
7. National Center for Complementary and Integrative Health, Melatonin: What You Need To Know: Melatonin has a large randomized controlled trial evidence base showing modest reductions in time to fall asleep